Results 261 to 270 of about 129,754 (292)
Some of the next articles are maybe not open access.

Immune-Mediated Neonatal Thrombocytopenia

NeoReviews, 2022
Immune-mediated thrombocytopenia in neonates is caused by the transplacental passage of maternally derived antiplatelet antibodies. The 2 most common causes include neonatal alloimmune thrombocytopenia, which leads to significant thrombocytopenia and risk of intracranial hemorrhage, and autoimmune thrombocytopenia, which is generally less severe.
Emily, Batton, Sandra L, Leibel
openaire   +2 more sources

Pediatric Immune Thrombocytopenia

Advances in Pediatrics
Pediatric immune thrombocytopenia (ITP) is a fairly common bleeding disorder PRESENTING with a decreased number of platelets. The typical clinical presentation involves mild bleeding symptoms with bruising and petechiae and occasional mucosal bleeding.
Moran, Gotesman   +4 more
openaire   +2 more sources

Immune Thrombocytopenia

New England Journal of Medicine, 2020
Virinder, Nohria, A Christopher, Macie
openaire   +3 more sources

Flucloxacillin‐induced immune thrombocytopenia

Transfusion, 2015
BACKGROUNDDrug‐induced immune thrombocytopenia (DITP) is an adverse drug reaction associated with platelet (PLT) destruction by drug‐dependent antibodies. Demonstration of drug‐dependent PLT antibodies is often difficult and can only be rendered by extensive laboratory testing.
Gregor, Jatzlauk   +7 more
openaire   +2 more sources

Immune Thrombocytopenia

1996
Abstract Hematologic abnormalities commonly occur among HIV-infected patients, usually reflecting either myelosuppression or hypoproliferation of all three cell lines. HIV- associated immune thrombocytopenia (ITP}, which typically results from rapid platelet destruction, is considered an exception to this general principle.
openaire   +1 more source

Methylprednisolone‐induced immune thrombocytopenia

American Journal of Hematology, 2019
Dubert, Marie   +12 more
openaire   +3 more sources

Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis

New England Journal of Medicine, 2021
Sue Pavord   +2 more
exaly  

Mycophenolate Mofetil for First-Line Treatment of Immune Thrombocytopenia

New England Journal of Medicine, 2021
Charlotte A Bradbury   +2 more
exaly  

Home - About - Disclaimer - Privacy